Literature DB >> 24642640

Risk factors for chronic mucus hypersecretion in individuals with and without COPD: influence of smoking and job exposure on CMH.

Akkelies E Dijkstra1, Kim de Jong, H Marike Boezen, Hans Kromhout, Roel Vermeulen, Harry J M Groen, Dirkje S Postma, Judith M Vonk.   

Abstract

BACKGROUND: Chronic mucus hypersecretion (CMH) is highly prevalent in smokers and associated with an accelerated lung function decline and chronic obstructive pulmonary disease (COPD). Several risk factors contribute to CMH and to COPD. It is, however, unknown if risk factors for CMH are similar in persons with and without COPD.
METHODS: 1479 persons with and 8529 without COPD, participating in the general population-based LifeLines cohort, completed questionnaires and underwent spirometry. Occupational exposure was assessed using the ALOHA+ job exposure matrix. Analyses were performed using multiple logistic regression models.
RESULTS: In COPD, a significantly higher risk for CMH was associated with higher pack-years smoking (per 10 pack-years) (OR=1.28; 1.12 to 1.46) and environmental tobacco smoke (ETS) (OR=2.06; 1.33 to 3.19). In non-COPD; male gender (OR=1.91; 1.51 to 2.41), higher Body Mass Index (OR=1.04; 1.01 to 1.06), higher pack-years smoking (OR=1.28; 1.14 to 1.44), current smoking (OR=1.50; 1.04 to 2.18), low and high exposure to mineral dust (OR=1.39; 1.04 to 1.87 and OR=1.60; 1.02 to 2.52), high exposure to gases & fumes (OR=2.19; 1.49 to 3.22). Significant interactions were found between COPD and exposure to gases & fumes (p=0.018) and aromatic solvents (p=0.038).
CONCLUSIONS: A higher risk for CMH was associated with higher pack-years smoking regardless of COPD status. However, a higher risk for CMH was associated with high occupational exposure to gases & fumes in individuals without COPD only.

Entities:  

Keywords:  Materials, exposures and occupational groups

Mesh:

Substances:

Year:  2014        PMID: 24642640     DOI: 10.1136/oemed-2013-101654

Source DB:  PubMed          Journal:  Occup Environ Med        ISSN: 1351-0711            Impact factor:   4.402


  10 in total

1.  Occupational exposures and chronic obstructive pulmonary disease. Causality established, time to focus on effect and phenotypes.

Authors:  Carlos H Martinez; George L Delclos
Journal:  Am J Respir Crit Care Med       Date:  2015-03-01       Impact factor: 21.405

Review 2.  The chronic bronchitis phenotype in chronic obstructive pulmonary disease: features and implications.

Authors:  Victor Kim; Gerard J Criner
Journal:  Curr Opin Pulm Med       Date:  2015-03       Impact factor: 3.155

3.  Dissecting the genetics of chronic mucus hypersecretion in smokers with and without COPD.

Authors:  Akkelies E Dijkstra; H Marike Boezen; Maarten van den Berge; Judith M Vonk; Pieter S Hiemstra; R Graham Barr; Kirsten M Burkart; Ani Manichaikul; Tess D Pottinger; Edward K Silverman; Michael H Cho; James D Crapo; Terri H Beaty; Per Bakke; Amund Gulsvik; David A Lomas; Yohan Bossé; David C Nickle; Peter D Paré; Harry J de Koning; Jan-Willem Lammers; Pieter Zanen; Joanna Smolonska; Ciska Wijmenga; Corry-Anke Brandsma; Harry J M Groen; Dirkje S Postma
Journal:  Eur Respir J       Date:  2014-09-18       Impact factor: 16.671

4.  A multifactoral analysis of 1452 patients for smoking sensation. An outpatient lab experience.

Authors:  Theodora Tsiouda; Paul Zarogoulidis; Dimitris Petridis; Nikolaos Pezirkianidis; Ioannis Kioumis; Lonny Yarmus; Haidong Huang; Qiang Li; Wolfgang Hohenforst-Schmidt; Konstantinos Porpodis; Dionysios Spyratos; Kosmas Tsakiridis; Georgia Pitsiou; Theodoros Kontakiotis; Paraskevi Argyropoulou; George Kyriazis; Konstantinos Zarogoulidis
Journal:  J Cancer       Date:  2014-05-10       Impact factor: 4.207

5.  Mucolytic Effectiveness of Tyloxapol in Chronic Obstructive Pulmonary Disease - A Double-Blind, Randomized Controlled Trial.

Authors:  Martin Koppitz; Charlotte Eschenburg; Emilia Salzmann; Martin Rosewich; Ralf Schubert; Stefan Zielen
Journal:  PLoS One       Date:  2016-06-16       Impact factor: 3.240

6.  Epidemiology and impact of chronic bronchitis in chronic obstructive pulmonary disease.

Authors:  Lies Lahousse; Leen J M Seys; Guy F Joos; Oscar H Franco; Bruno H Stricker; Guy G Brusselle
Journal:  Eur Respir J       Date:  2017-08-10       Impact factor: 16.671

Review 7.  Occupational COPD and job exposure matrices: a systematic review and meta-analysis.

Authors:  Steven Sadhra; Om P Kurmi; Sandeep S Sadhra; Kin Bong Hubert Lam; Jon G Ayres
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-02-22

8.  Chronic bronchitis: High prevalence in never smokers and underdiagnosis- A population-based study in Colombia.

Authors:  Mauricio Gonzalez-Garcia; Andres Caballero; Claudia Jaramillo; Carlos A Torres-Duque
Journal:  Chron Respir Dis       Date:  2018-04-18       Impact factor: 2.444

9.  Impact of current cough on health-related quality of life in patients with COPD.

Authors:  Gaëtan Deslee; Pierre-Régis Burgel; Roger Escamilla; Pascal Chanez; Isabelle Court-Fortune; Pascale Nesme-Meyer; Graziella Brinchault-Rabin; Thierry Perez; Gilles Jebrak; Denis Caillaud; Jean-Louis Paillasseur; Nicolas Roche
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-09-13

10.  Nicotine-Free e-Cigarette Vapor Exposure Stimulates IL6 and Mucin Production in Human Primary Small Airway Epithelial Cells.

Authors:  Shaan Gellatly; Nicole Pavelka; Taylor Crue; Kelly S Schweitzer; Brian J Day; Elysia Min; Mari Numata; Dennis R Voelker; April Scruggs; Irina Petrache; Hong Wei Chu
Journal:  J Inflamm Res       Date:  2020-04-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.